Open original FDA record ↗Recall record
- FDA identifier
- Z-0779-2017
- Company in FDA record
- PerkinElmer Health Sciences, Inc.
- FDA classification date
- Dec 16, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76 67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.
Source facts
- Action
- PerkinElmer initiated recall on November 16, 2016, delivered to the end customer by email facilitated through the PerkinElmer Technical Support group located in Akron Ohio. Technical Support will be asked to make sure the customers receive the Recall Letter and understand the recommended actions. Users asked to inspect inventory, discontinue use destroy the kits and complete the Response Forms and Destruction.Replacement kits will shipped.
- Initiated
- 2016-11-16
- Root cause
- Other
- Terminated
- 2017-07-05
- Distribution
- CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,
- Recall number
- Z-0779-2017
- Recall status
- Terminated
- CDRH record ID
- 151081
- FDA classified
- 2016-12-16
- Recall event number
- 75708